Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study - 22/02/21
, Muralidhar H. Premkumar, MD 2, Kara L. Calkins, MD 3, Mark Puder, MD, PhD 4Abstract |
Objective |
To compare the aspartate aminotransferase to platelet ratio index, liver transplantation, and mortality rates between children with intestinal failure-associated liver disease who received fish oil lipid emulsion (FOLE) or soybean oil intravenous lipid emulsion (SOLE).
Study design |
In this multicenter integrated analysis, FOLE recipients (1 g/kg/d) (n = 189) were compared with historical controls administered SOLE (≤3 g/kg/d) (n = 73).
Results |
Compared with SOLE, FOLE recipients had a higher direct bilirubin level at baseline (5.8 mg/dL vs 3.0 mg/dL; P < .0001). Among FOLE recipients, 65% experienced cholestasis resolution vs 16% of SOLE recipients (P < .0001). The aspartate aminotransferase to platelet ratio index scores improved in FOLE recipients (1.235 vs 0.810 and 0.758, P < .02) but worsened in SOLE recipients (0.540 vs 2.564 and 2.098; P ≤ .0003) when baseline scores were compared with cholestasis resolution and end of study, respectively. Liver transplantation was reduced in FOLE vs SOLE (4% vs 12%; P = .0245). The probability of liver transplantation in relation to baseline direct or conjugated bilirubin (DB) was lower in FOLE vs SOLE recipients (1% vs 9% at DB of 2 mg/dL; 8% vs 35% at DB of 12.87 mg/dL; P = .0022 for both). Death rates were similar (FOLE vs SOLE: 10% vs 14% at DB of 2 mg/dL; 17% vs 23% at a DB of 12.87 mg/dL; P = .36 for both).
Conclusions |
FOLE recipients experienced a higher rate of cholestasis resolution, lower aspartate aminotransferase to platelet ratio index, and fewer liver transplants compared with SOLE. This study demonstrates that FOLE may be the preferred parenteral lipid emulsion in children with intestinal failure-associated liver disease when DB reaches 2 mg/dL.
Trial registration |
Clinicaltrials.gov: NCT00910104 and NCT00738101.
Le texte complet de cet article est disponible en PDF.Keywords : soybean oil, intravenous lipid emulsion, Omegaven, APRI score, intestinal failure associated liver disease, liver transplant
Abbreviations : ALT, APRI, AST, BCH, DB, FOLE, IFALD, PELD, SOLE, TCH, UCLA
Plan
| K.G. is a consultant for Pronova/BASF, Northsea Therapeutics, Xellia Pharmaceuticals, Pfizer Pediatric Center of Excellence, and Baxter, and has received research support from Northsea Therapeutics, Otsuka Pharmaceutical Company, Alcresta, Fresenius Kabi, the Food and Drug Administration Orphan Drug Development Grant Program, and the March of Dimes. M.Pu. is a consultant for Pronova/BASF, and Northsea Therapeutics, and has received research support from Northsea Therapeutics, Otsuka Pharmaceutical Company, Alcresta, Fresenius Kabi, and the FDA Orphan Drug Development Grant Program, and the March of Dimes; and patent/royalties for Omegaven are forthcoming. K.C. is a consultant for Fresenius Kabi, Mead Johnson, Prolacta, and Baxter, and has received research support from Fresenius Kabi and National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) KL2TR000122. M.Pr. is a consultant for Fresenius Kabi. |
Vol 230
P. 46 - mars 2021 Retour au numéro
Article précédent
- 50 Years Ago in The Journal of Pediatrics : Diagnosing the Etiology of Childhood Diarrhea by Clinical Features: An Update
- Chabungbam Smilie, Piyush Gupta
- Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders
- Ryan W. Himes, Eric H. Chiou, Karen Queliza, Dror S. Shouval, Raz Somech, Suneet Agarwal, Kunal Jajoo, David S. Ziegler, Christian P. Kratz, James Huang, Tiffany L. Lucas, Kasiani C. Myers, Adam S. Nelson, Courtney D. DiNardo, Blanche P. Alter, Neelam Giri, Payal P. Khincha, Lisa J. McReynolds, Carlo Dufour, Filomena Pierri, Frederick D. Goldman, Youmna Sherif, Sharon A. Savage, Tamir Miloh, Alison A. Bertuch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?